TCI Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

TCI Wealth Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37	Closed	-$2K	–	2583
2022 Q2	$2K	Sell	37 -143	-79%	-$11.7K	﹤0.01%	2053
2022 Q1	$21K	Sell	180 -54	-23%	-$6.3K	﹤0.01%	688
2021 Q4	$35K	Buy	234 +51	+28%	+$6.88K	0.01%	495
2021 Q3	$22K	Buy	183 +4	+2%	+$441	﹤0.01%	653
2021 Q2	$17K	Buy	179 +63	+54%	+$5.62K	﹤0.01%	669
2021 Q1	$10K	Buy	116 +64	+123%	+$5.95K	﹤0.01%	870
2020 Q4	$5K	Hold	52	–	–	﹤0.01%	910
2020 Q3	$6K	Buy	52 +15	+41%	+$1.58K	﹤0.01%	732
2020 Q2	$4K	Hold	37	–	–	﹤0.01%	843
2020 Q1	$2K	Hold	37	–	–	﹤0.01%	1100
2019 Q4	$2K	Hold	37	–	–	﹤0.01%	1209
2019 Q3	$2K	Hold	37	–	–	﹤0.01%	1153
2019 Q2	$2K	Hold	37	–	–	﹤0.01%	1072
2019 Q1	$2K	Hold	37	–	–	﹤0.01%	1088
2018 Q4	$1K	Buy	+37	New	+$1.31K	﹤0.01%	1314

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TCI Wealth Advisors's TNDM Position: Q3 2022 in Review

TCI Wealth Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 37 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in TNDM in Q4 2018 and held it in 15 quarters. The position peaked at $35K in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

TCI Wealth Advisors reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
TCI Wealth Advisors sold 37 Tandem Diabetes Care shares in Q3 2022, an estimated $2K.
TCI Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 15 quarters.
TCI Wealth Advisors's Tandem Diabetes Care position peaked at $35K in Q4 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on TCI Wealth Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.